Cancer Diagnosis and Therapy
OUR SERVICES
FDG-PET/CT
A Nuclear Medicine imaging procedure used to detect metabolically active malignant lesions. A non-invasive approach to accurate diagnosis and staging for the optimal management of cancer patients. 22,000+ patients scanned since 2015.
FPSMA-PET/CT
Named as a top medical innovation by Cleveland Clinic in 2022. PSMA PET scan has greater sensitivity and can detect prostate cancer metastases sooner, allowing clinicians to better serve patients and make treatment decisions earlier. 800+ patients scanned since 2019.
FBB
A procedure that is primarily used for the evaluation of beta amyloid neuritic plaque density. An effective tool to differentiate Alzheimer’s Disease from other forms of Dementia. Khealth Corp. is the only manufacturer in the PH granted with exclusive rights for the production of FBB (Neuraceq®).
LuPSMA-PET/CT
Partnered with FPSMA- PET/CT scan, LuPSMA offers a Theranostics approach to treatment of metastatic castration- resistant prostate cancer (mCRPC). Theranostics takes advantage of the specificity of PSMA for PCa cells and has demonstrated promising results in the clinic.